BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

616 hedge funds and large institutions have $1.57B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2019 Q4 according to their latest regulatory filings, with 616 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
616
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$48M
Puts
$8.03M
Net Calls
Net Calls Change

Top Buyers

1
+$150M
2
+$107M
3
+$91.4M
4
Viking Global Investors
Viking Global Investors
Connecticut
+$78.3M
5
ACM
Abrams Capital Management
Massachusetts
+$69.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
101
$1.48M
102
$1.45M
103
$1.42M
104
$1.33M
105
$1.27M
106
$1.26M
107
$1.25M
108
$1.25M
109
$1.22M
110
$1.17M
111
$1.11M
112
$1.1M
113
$1.08M
114
$1.07M
115
$1.05M
116
$972K
117
$952K
118
$899K
119
$888K
120
$885K
121
$841K
122
$830K
123
$824K
124
$806K
125
$804K
3 4
5
6 7